x min read

Announcement Affects: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), SinoCoking Coal and Coke Chemical Industries, Inc. (NASDAQ:SCOK), Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Announcement Affects: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), SinoCoking Coal and Coke Chemical Industries, Inc. (NASDAQ:SCOK), Valeant Pharmaceuticals International, Inc. (NYSE:VRX)
Written by
Ryan Mitchell
Published on
October 21, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi (SNY) released that the first patients have been dosed in a Phase 3 clinical study of dupilumab, an investigational therapy so as to blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis that is not adequately controlled with topical AD medications. On the other consideration, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) begun last trade with a price of $367.79 and throughout the trading session climbed at $369.00. The day-trade ended with a lose of -0.95% to closed at $366.13. The stock is going forward its fifty-two week low with 42.08% and lagging behind from its 52 week high price with -2.85%.SinoCoking Coal and Coke Chemical Industries, Inc. (NASDAQ:SCOK) reported that as of the morning of October 18 China time its aboveground facility for the conversion of carbon dioxide into clean-burning syngas had begun operations and was producing and transporting syngas to customers in and around Pingdingshan. Shares of SinoCoking Coal and Coke Chemical Industries, Inc. (NASDAQ:SCOK) opened at $3.57 with 23.96 million outstanding shares and hit to its highest price of $4.44 during the day and finally closed at $3.74 by scoring 59.15%. In the whole session, it traded on volume of 28.38 Million shares, which turned higher than its average volume.Valeant Pharmaceuticals International, Inc. (NYSE:VRX) released its third quarter (Sep) earnings of $2.11 a share, excluding non-recurring items, $0.12 improved than the Capital IQ Consensus anticipates of $1.99. The firm guided up on Sept 24.Total similar store sales organic growth was 19 percent, including impact from generics Bausch + Lomb organic growth was 12%, adjusted only for foreign exchange. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) stock hit highest price at $127.43, beginning with a price of $121.13 to the closed at 124.78 by an increase of 3.80% with a day range of $120.12-$127.43. The total market capitalization remained 41.853 Billion, total volume of 3.4 Million shares held in the session was surprisingly higher than its average volume of 2834.55 shares.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.